Table 1 Patient characteristics Patient... | American Society of Hematology

Table 1

Patient characteristics

Patient	Sex	Gestational age, wk	Disease	Treatment	Time of death after birth
1	F	27	Hydropic infant with teratoma	In utero laser treatment	Birth
2	F	33	Asphyxia with multiorgan failure	Resuscitation	2 h
3	F	40	Asphyxia with multiorgan failure	Resuscitation	24 h
4	M	31	Hydropic infant with lung hypoplasia	None	Birth
5	M	22	Unknown	None	Birth
6	F	32	Unknown	None	Birth
7	M	24	Unknown	None	Birth
8	F	37	Ileum atresia	None	N/A
9	M	37	Jejunum atresia	None	N/A
10	M	40	Meconium ileus	None	N/A
11	M	40	Ileum atresia	None	N/A

Patient	Sex	Gestational age, wk	Disease	Treatment	Time of death after birth
1	F	27	Hydropic infant with teratoma	In utero laser treatment	Birth
2	F	33	Asphyxia with multiorgan failure	Resuscitation	2 h
3	F	40	Asphyxia with multiorgan failure	Resuscitation	24 h
4	M	31	Hydropic infant with lung hypoplasia	None	Birth
5	M	22	Unknown	None	Birth
6	F	32	Unknown	None	Birth
7	M	24	Unknown	None	Birth
8	F	37	Ileum atresia	None	N/A
9	M	37	Jejunum atresia	None	N/A
10	M	40	Meconium ileus	None	N/A
11	M	40	Ileum atresia	None	N/A

Patients 1-4 were included in the initial immunohistochemical study using autopsy material from neonates. Patients 5-10 represent patients from whom fresh newborn tissue samples were obtained shortly after birth for the ex vivo HIV-1 infection studies and flow cytometry. Gut tissue from patients 7 and 11 was used in the sequencing analyses of the TCRβ-chain repertoire.

N/A indicates not available.

View Large

This Feature Is Available To Subscribers Only